Annual Total Long Term Liabilities
$30.93 M
+$6.03 M+24.23%
December 31, 2023
Summary
- As of February 26, 2025, FENC annual total long term liabilities is $30.93 million, with the most recent change of +$6.03 million (+24.23%) on December 31, 2023.
- During the last 3 years, FENC annual total long term liabilities has risen by +$30.93 million (+100.00%).
- FENC annual total long term liabilities is now at all-time high.
Performance
FENC Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$56.66 M
-$112.00 K-0.20%
September 30, 2024
Summary
- As of February 26, 2025, FENC quarterly total long term liabilities is $56.66 million, with the most recent change of -$112.00 thousand (-0.20%) on September 30, 2024.
- Over the past year, FENC quarterly long term liabilities has stayed the same.
- FENC quarterly long term liabilities is now -0.20% below its all-time high of $56.77 million, reached on June 30, 2024.
Performance
FENC Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
FENC Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +24.2% | 0.0% |
| 3 y3 years | +100.0% | 0.0% |
| 5 y5 years | +100.0% | 0.0% |
FENC Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +520.1% | -0.2% | +1320.0% |
| 5 y | 5-year | at high | -100.0% | -0.2% | -100.0% |
| alltime | all time | at high | -100.0% | -0.2% | -100.0% |
Fennec Pharmaceuticals Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $56.66 M(-0.2%) |
| Jun 2024 | - | $56.77 M(+0.8%) |
| Mar 2024 | - | $56.34 M(+82.1%) |
| Dec 2023 | $30.93 M(+24.2%) | $30.93 M(+20.6%) |
| Sep 2023 | - | $25.65 M(+1.0%) |
| Jun 2023 | - | $25.39 M(+1.0%) |
| Mar 2023 | - | $25.14 M(+1.0%) |
| Dec 2022 | $24.90 M(+399.2%) | $24.90 M(+0.9%) |
| Sep 2022 | - | $24.69 M(+518.7%) |
| Jun 2022 | - | $3.99 M(-11.1%) |
| Mar 2022 | - | $4.49 M(-10.0%) |
| Dec 2021 | $4.99 M(>+9900.0%) | $4.99 M(+0.0%) |
| Sep 2021 | - | $4.99 M(+0.0%) |
| Jun 2021 | - | $4.99 M(>+9900.0%) |
| Mar 2021 | - | $0.00(0.0%) |
| Dec 2020 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2020 | - | $0.00(0.0%) |
| Jun 2020 | - | $0.00(0.0%) |
| Mar 2020 | - | $0.00(0.0%) |
| Dec 2019 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2019 | - | $0.00(0.0%) |
| Jun 2019 | - | $0.00(0.0%) |
| Mar 2019 | - | $0.00(0.0%) |
| Dec 2018 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2018 | - | $0.00(0.0%) |
| Jun 2018 | - | $0.00(0.0%) |
| Mar 2018 | - | $0.00(0.0%) |
| Dec 2017 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2017 | - | $0.00(0.0%) |
| Jun 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) |
| Dec 2016 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2016 | - | $0.00(0.0%) |
| Jun 2016 | - | $0.00(0.0%) |
| Mar 2016 | - | $0.00(0.0%) |
| Dec 2015 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2015 | - | $0.00(0.0%) |
| Jun 2015 | - | $0.00(0.0%) |
| Mar 2015 | - | $0.00(0.0%) |
| Dec 2014 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2014 | - | $0.00(0.0%) |
| Jun 2014 | - | $0.00(0.0%) |
| Mar 2014 | - | $0.00(0.0%) |
| Dec 2013 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2013 | - | $0.00(0.0%) |
| Jun 2013 | - | $0.00(0.0%) |
| Mar 2013 | - | $0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2012 | - | $0.00(0.0%) |
| Jun 2012 | - | $0.00(0.0%) |
| Mar 2012 | - | $0.00(0.0%) |
| Dec 2011 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2011 | - | $0.00(0.0%) |
| Jun 2011 | - | $0.00(0.0%) |
| Mar 2011 | - | $0.00(0.0%) |
| Dec 2010 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2010 | - | $4.69 M(-35.4%) |
| Jun 2010 | - | $7.26 M(>+9900.0%) |
| Mar 2010 | - | $7000.00(0.0%) |
| Dec 2009 | $7000.00(-98.8%) | $7000.00(-96.7%) |
| Sep 2009 | - | $214.00 K(-61.2%) |
| Jun 2009 | - | $552.00 K(+1.1%) |
| Mar 2009 | - | $546.00 K(-5.4%) |
| Dec 2008 | $577.00 K(-12.4%) | $577.00 K(-3.8%) |
| Sep 2008 | - | $600.00 K(-2.6%) |
| Jun 2008 | - | $616.00 K(-3.3%) |
| Mar 2008 | - | $637.00 K(-3.3%) |
| Dec 2007 | $659.00 K(-0.9%) | $659.00 K(-8.6%) |
| Sep 2007 | - | $721.00 K(+1.7%) |
| Jun 2007 | - | $709.00 K(+3.4%) |
| Mar 2007 | - | $686.00 K(+3.2%) |
| Dec 2006 | $665.00 K(-88.4%) | $665.00 K(-87.3%) |
| Sep 2006 | - | $5.22 M(-3.3%) |
| Jun 2006 | - | $5.40 M(-3.2%) |
| Mar 2006 | - | $5.57 M(-2.6%) |
| Dec 2005 | $5.72 M(-21.1%) | $5.72 M(-20.7%) |
| Sep 2005 | - | $7.22 M(+2.1%) |
| Jun 2005 | - | $7.07 M(-3.6%) |
| Mar 2005 | - | $7.34 M(-1.4%) |
| Sep 2004 | - | $7.44 M(+2.5%) |
| Jun 2004 | $7.26 M(-21.6%) | $7.26 M(-4.6%) |
| Mar 2004 | - | $7.61 M(-4.7%) |
| Dec 2003 | - | $7.98 M(-13.0%) |
| Sep 2003 | - | $9.17 M(-1.0%) |
| Jun 2003 | $9.26 M(>+9900.0%) | $9.26 M(+21.7%) |
| Mar 2003 | - | $7.61 M(+6.0%) |
| Dec 2002 | - | $7.18 M(>+9900.0%) |
| Sep 2002 | - | $25.90 K(-38.6%) |
| Jun 2002 | $42.20 K(-61.7%) | $42.20 K(-21.9%) |
| Mar 2002 | - | $54.00 K(-20.8%) |
| Dec 2001 | - | $68.20 K(-20.2%) |
| Sep 2001 | - | $85.50 K(-22.4%) |
| Jun 2001 | $110.20 K(-5.8%) | $110.20 K(+24.1%) |
| Dec 2000 | - | $88.80 K |
| Jun 2000 | $117.00 K | - |
FAQ
- What is Fennec Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for Fennec Pharmaceuticals?
- What is Fennec Pharmaceuticals annual total long term liabilities year-on-year change?
- What is Fennec Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Fennec Pharmaceuticals?
- What is Fennec Pharmaceuticals quarterly long term liabilities year-on-year change?
What is Fennec Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of FENC is $30.93 M
What is the all time high annual total long term liabilities for Fennec Pharmaceuticals?
Fennec Pharmaceuticals all-time high annual total long term liabilities is $30.93 M
What is Fennec Pharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, FENC annual total long term liabilities has changed by +$6.03 M (+24.23%)
What is Fennec Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of FENC is $56.66 M
What is the all time high quarterly long term liabilities for Fennec Pharmaceuticals?
Fennec Pharmaceuticals all-time high quarterly total long term liabilities is $56.77 M
What is Fennec Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, FENC quarterly total long term liabilities has changed by $0.00 (0.00%)